For US Residents Only | Visit Health Care Professionals Site
Image: Sanofi Pasteur Logo
Image: Fluzone® Quadrivalent vaccine can help better protect you from the flu.

Get broad protection from the flu
with Fluzone Quadrivalent vaccine

Image: Find Fluzone Vaccines Near You

Search by Practice or Pharmacy

Search by practice or pharmacy (optional)

Find it now

Ask your health care provider about Fluzone
Intradermal Quadrivalent vaccine or Fluzone High-Dose vaccine.

Image: Fluzone® Quadrivalent influenza vaccine can help better protect you from the flu.

Get broad protection
from the flu with
Fluzone Quadrivalent
vaccine

Fluzone Quadrivalent vaccine is designed to help protect people 6 months and older against 4 different strains of the flu: 2 influenza A viruses and 2 influenza B viruses.1 Current trivalent flu vaccines help protect against 2 influenza A viruses but only 1 influenza B virus.2

Helping to protect against 2 influenza B viruses is important. Data show that influenza B viruses are responsible for a substantial burden of flu-related hospitalizations and complications, especially in children.3,4

Fluzone Quadrivalent vaccine is the only vaccine approved to help protect children as young as 6 months against 4 different strains of the flu.1 Fluzone Quadrivalent vaccine is also safe for people who are at higher risk for complications from the flu.1,4-7

The Centers for Disease Control and Prevention (CDC) recommends everyone 6 months of age and older, with rare exception, receive an annual flu vaccination8,9

Children, especially those younger than 5 years of age, are at high risk for developing complications from the flu. Among children younger than 18 years during the 2012—2013 flu season10:

  • 90% of deaths occurred in unvaccinated children

  • 40% of deaths occurred in children with no recognized chronic health problems

Children 6 months through 8 years of age may need 2 doses of the flu vaccine this flu season to help optimize their immune response; however, many children who need 2 doses receive only 1 dose.8,11 During the 2010—2011 flu season, on average, fewer than 15% of children younger than 9 years of age received the recommended second dose of the flu vaccine.11

Depending on your age or your child's age, different dosage forms of Fluzone vaccines are available.1,12-14 Talk to your health care provider about the correct vaccine for you or your child and to schedule your vaccination.

For children 6 months through 8 years of age

Children in this age group may need 2 doses of influenza vaccine 1 month apart.8 Talk to your health care provider to determine if 2 doses are necessary.

Studies have shown that Fluzone Quadrivalent vaccine is safe for people 6 months of age and older.1 Side effects of Fluzone Quadrivalent vaccine include pain, redness, and swelling at the injection site, fever, fatigue, and muscle aches.1

Fluzone Quadrivalent vaccine is not appropriate for everyone. Children who should not get Fluzone Quadrivalent vaccine include those who1:

  • Are younger than 6 months of age1

  • Have ever had a severe allergic reaction to a flu vaccine1

  • Are severely allergic to eggs or egg products1

Fluzone Quadrivalent vaccine is available for persons 6 months of age and older.1 But for you or your loved ones 18 through 64 years of age, consider Fluzone Intradermal Quadrivalent vaccine — the flu vaccine with the 90% smaller needle.12,15 For you or your loved ones 65 years of age or older, consider Fluzone High-Dose vaccine, the flu vaccine with 4 times the antigen of a regular flu shot for a stronger immune response to the flu.13,14,16

There’s a Fluzone vaccine for you.


Have questions? Get answers.

How can I learn more about influenza?

There’s a Fluzone vaccine for you.

Important Safety Information

Indication

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines are given to help prevent influenza disease caused by influenza A and B strains contained in each vaccine.

Fluzone Quadrivalent vaccine is given to people 6 months of age and older. Fluzone Intradermal Quadrivalent vaccine is given to people 18 through 64 years of age. Fluzone High-Dose vaccine is given to people 65 years of age and older.

Safety Information

Side effects to Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines include pain and swelling at the injection site (also itching at the injection site and shivering in adults receiving Fluzone Intradermal Quadrivalent vaccine); muscle aches, fatigue, and headache (also irritability, abnormal crying, drowsiness, appetite loss, vomiting, and fever in young children receiving Fluzone Quadrivalent vaccine). Itching, redness, swelling, and firmness at the injection site have occurred more frequently with vaccine administered into the skin compared to vaccine administered into the muscle. Other side effects may occur.

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines should not be administered to anyone with a severe allergic reaction (eg, anaphylaxis) to any vaccine component, including eggs, egg products, or thimerosal (the multidose vial is the only presentation containing thimerosal), or to a previous dose of any influenza vaccine.

Tell the doctor if you/your child has ever experienced Guillain-Barré syndrome (severe muscle weakness) after a previous dose of influenza vaccine. If you notice any other problems or symptoms following vaccination, please contact your health care professional immediately. Vaccination with Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, or Fluzone High-Dose vaccine may not protect all individuals.

For more information about Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, or Fluzone High-Dose vaccine, talk to your health care professional and see complete Patient Information.

References

  1. Fluzone Quadrivalent vaccine [Prescribing Information]. Swiftwater, PA: Sanofi Pasteur Inc.; 2015.
  2. Hamborsky J, Kroger A, Wolfe C. Influenza. In: Hamborsky J, Kroger A, Wolfe C, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book). 13th ed. Washington, DC: Public Health Foundation; 2015:187–208.
  3. Belshe RB. The need for quadrivalent vaccine against seasonal influenza. Vaccine. 2010;28(suppl 4):D45–D53.
  4. Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother. 2012;8(1):81–88.
  5. Aspinall R, Del Giudice G, Effros RB, Grubeck-Loebenstein B, Sambhara S. Challenges for vaccination in the elderly. Immun Ageing. 2007;4:9.
  6. Monto AS, Ansaldi F, Aspinall R, et al. Influenza control in the 21st century: optimizing protection of older adults. Vaccine. 2009;27(37):5043–5053.
  7. Treanor JJ. Influenza viruses, including avian influenza and swine influenza. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA: Churchill Livingstone Elsevier; 2010:2265–2288.
  8. Centers for Disease Control and Prevention (CDC). Recommended immunization schedules for persons aged 0 through 18 years ‐ United States, 2015. http://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-child-combined-schedule.pdf. Accessed June 10, 2015.
  9. CDC. Recommended adult immunization schedule: United States ‐ 2015. http://www.cdc.gov/vaccines/schedules/downloads/adult/adult-combined-schedule.pdf. Accessed June 10, 2015.
  10. CDC. CDC Reports About 90 Percent of Children Who Died From Flu This Season Not Vaccinated. http://www.cdc.gov/flu/spotlights/children-flu-deaths.htm. Accessed June 10, 2015.
  11. CDC. Influenza Vaccination Distribution and Coverage, United States, 2010‐11 and 2011‐12 Seasons. Presented at: Meeting of the ACIP; October 2011.
  12. Fluzone Intradermal Quadrivalent vaccine [Prescribing Information]. Swiftwater, PA: Sanofi Pasteur Inc.; 2015.
  13. Fluzone High-Dose vaccine [Prescribing Information]. Swiftwater, PA: Sanofi Pasteur Inc.; 2015.
  14. Fluzone vaccine [Prescribing Information]. Swiftwater, PA: Sanofi Pasteur Inc.; 2015
  15. Hamborsky J, Kroger A, Wolfe C. Vaccine Administration. In: Hamborsky J, Kroger A, Wolfe C, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book). 13th ed. Washington, DC: Public Health Foundation; 2015:79–106.
  16. CDC. Licensure of a high-dose inactivated influenza vaccine for persons aged ≥65 years (Fluzone High-Dose) and guidance for use – United States, 2010. MMWR. 2010;59(16):485–486.

PLEASE NOTE

By clicking on this link, you will be leaving this Sanofi Pasteur website and going to another, entirely independent website. Sanofi Pasteur provides this link as a service to its website visitors; however, it takes no responsibility for the information presented on any website but its own.

This link has opened in a new window. To return to your original site, please close this new window.

Click here to go to the page you requested. Click here to close this window and return to the site.